title: HFE based re-evaluation of heterozygous hemochromatosis.
abstract: Homozygosity for the C282Y mutation in the HFE gene is strongly associated with hereditary hemochromatosis. More than one subject out of 10 in the general population is a heterozygote for the C282Y mutation. In this study, we address whether or not conclusions drawn from HLA-based family studies regarding the expression of heterozygous hemochromatosis are applicable to C282Y heterozygotes. The correlation between HLA-inferred and HFE genotypes and the variation of serum iron tests according to HFE genotype and other factors were studied in persons from well-characterized hemochromatosis pedigrees. Subjects were tested for both C282Y and H63D mutations. The following factors were studied: age, sex, alcohol consumption, body mass index, liver function tests, serum lipids and glucose, serum iron, transferrin saturation, and ferritin. HLA-inferred heterozygotes were C282Y heterozygotes in only 70% and compound heterozygotes (i.e., heterozygotes for both C282Y and H63D) in 20%. C282Y heterozygotes did not differ from wild type homozygotes in terms of serum iron tests. Only compound heterozygotes presented with slightly increased transferrin saturation. On the other hand, increased serum ferritin was strongly associated with overweight or lipidic or glucose abnormalities. C282Y heterozygotes selected from family studies do not have greater serum iron tests than wild type homozygotes, except for compound heterozygotes, and therefore should not require special followup. The discovery of abnormal iron tests in a C282Y heterozygote should lead to workup for other causes of iron overload.
authors.affiliation: Clinique des Maladies du Foie, Rennes, France. moirand@sunaimed.univ-rennes1.fr
authors.forename: Romain
authors.initials: R
authors.lastname: Moirand
authors.forename: Dominique
authors.initials: D
authors.lastname: Guyader
authors.forename: Michel Henry
authors.initials: MH
authors.lastname: Mendler
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Jouanolle
authors.forename: Jean Yves
authors.initials: JY
authors.lastname: Le Gall
authors.forename: Véronique
authors.initials: V
authors.lastname: David
authors.forename: Pierre
authors.initials: P
authors.lastname: Brissot
authors.forename: Yves
authors.initials: Y
authors.lastname: Deugnier
mesh_terms: D019943:Amino Acid Substitution; D005260:Female; D006680:HLA Antigens / Q000235:genetics; D006432:Hemochromatosis / Q000235:genetics*; D000071020:Hemochromatosis Protein; D006579:Heterozygote; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D009154:Mutation
chemical_list: C103673:HFE protein, human; D006680:HLA Antigens; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D007501:Iron